Flovent diskus 100 side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
2. Cough
3. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
4. Diarrhoea
5. Dysphonia (speech disorder attributable to a disorder of phonation)
6. Heart rate increased
7. Hypoaesthesia (reduced sense of touch or sensation)
8. Injection site haematoma (localized swelling filled with blood at injection site)
9. Aortic thrombosis (formation of a blood clot inside aorta)

male:

1. Aggression
2. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
3. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
4. Collapse (sudden functional breakdown)
5. Dry skin
6. Dyspnoea (difficult or laboured respiration)
7. Ear infection
8. Respiratory syncytial virus infection (viral disease of respiratory system)
9. Weight decreased

0-1:

1. Cough
2. Ear infection

2-9:

1. Aggression
2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
3. Injection site haematoma (localized swelling filled with blood at injection site)

10-19:

1. Akathisia (a movement disorder characterized by a feeling of inner restlessness)

20-29:

1. Collapse (sudden functional breakdown)

30-39:

1. Dysphonia (speech disorder attributable to a disorder of phonation)
2. Hypoaesthesia (reduced sense of touch or sensation)

40-49:

n/a

50-59:

1. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
2. Diarrhoea

60+:

1. Aortic thrombosis (formation of a blood clot inside aorta)
2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
3. Dry skin
4. Dyspnoea (difficult or laboured respiration)
5. Heart rate increased

< 1 month:

1. Dyspnoea (difficult or laboured respiration)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Aortic thrombosis (formation of a blood clot inside aorta)
2. Diarrhoea
3. Dry skin
4. Dysphonia (speech disorder attributable to a disorder of phonation)
5. Ear infection
6. Heart rate increased
7. Hypoaesthesia (reduced sense of touch or sensation)
8. Injection site haematoma (localized swelling filled with blood at injection site)
9. Respiratory syncytial virus infection (viral disease of respiratory system)
10. Weight decreased